This review aims to dissect the roles of PARK genes - PARK1/4, PARK2, PARK5, PARK6, PARK7, PARK8, PARK13, PARK14, and PARK18 in both PD and melanoma, thereby fostering novel therapeutic strategies for these debilitating conditions. This evidence concerns the gene SNCA and Parkinson disease.